Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 0.32% for the current model date.
BlackTreeCVE IntelligenceMirion Medical · EC2 Software NMIS BioDose
High technical severity; prioritise exposed affected systems while verifying vendor guidance.
High technical severity; prioritise exposed affected systems while verifying vendor guidance.
Patch availableNMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
A client/server product performs authentication within client code but not in server code, allowing server-side authentication to be bypassed via a modified client that omits the authentication check.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
A client/server product performs authentication within client code but not in server code, allowing server-side authentication to be bypassed via a modified client that omits the authentication check.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-603: Use of Client-Side Authentication. A client/server product performs authentication within client code but not in server code, allowing server-side authentication to be bypassed via a modified client that omits the authentication check.
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:NCommon Vulnerability Scoring System 4.0: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 2 Dec 2025 · Last source change 9 Dec 2025, 17:03 UTC · CWE-603 · Use of Client-Side Authentication
Core structured fields are present and their contributing authorities are shown above.